BBH

Featured

Why Biotech ETFs May Be the Better Choice

By Tom LydonJune 17, 2009

Featured

How Biotech ETFs Can Rise Above Challenges

By Tom LydonMay 12, 2009

Featured

How Biotech ETFs Are Overcoming Sector’s Trials

By Tom LydonMarch 24, 2009

Featured

Midday Market Update: Downgrades and Mergers Lead Markets and ETFs

By Tom LydonMarch 12, 2009

Featured

What Stem Cell Research Means for Biotech ETFs

By Tom LydonMarch 10, 2009

Featured

How Obama’s Health Care Reform Impacts Biotech ETFs

By Tom LydonMarch 5, 2009

Featured

Midday Market Update: Can New Program Spark an ETF Rally?

By Tom LydonMarch 3, 2009

Featured

Health Care ETFs’ $140 Billion Boost

By Tom LydonFebruary 19, 2009

Featured

Why Biotech, ETFs Want Piece of Bailout

By Tom LydonDecember 11, 2008

Featured

Biotech ETFs Stay Healthy Despite Market Ills

By Tom LydonOctober 22, 2008

Featured

ETF Selecting Doesn’t Have To Be Like A Box Of Chocolates

By Tom LydonSeptember 3, 2008

Alternative ETFs

Biotechnology ETFs Growing…Like Genetically Modified Crops?

By Tom LydonJuly 16, 2008

Featured

Can Biotech And Agriculture ETFs Get Acreage With Your Money?

By Tom LydonJuly 10, 2008

Previous 1 … 7 8 9